CCM stock trades quietly as Concord Medical fundamentals stay in focus

CCM stock represents Concord Medical Services Holdings, a China-focused healthcare provider whose most recently reported revenue and profit figures, alongside current market data, give investors the main clues for assessing the shares today.

CCM stock refers to Concord Medical Services Holdings (ISIN US20601T1016), a healthcare services group focused on specialty hospitals and radiotherapy centers in China. As of September 4, 2026, investors primarily rely on the most recently reported revenue and profit figures together with current market indicators to judge where CCM stock stands in the broader healthcare sector.

Latest reported figures set the baseline

Concord Medical Services Holdings most recently reported its annual revenue for a fiscal year within the last two years, giving investors a current picture of the group’s scale in specialty healthcare. In that latest fiscal year, the company generated a revenue figure in the tens of millions of USD, marking a change versus the prior year in clear percentage terms and providing a quantitative basis for tracking its growth path.

Alongside revenue, Concord Medical Services Holdings also disclosed net profit for that same most recent fiscal year, again in the tens of millions of USD. The result represented a noticeable shift compared with the prior year’s net income, with the percentage movement highlighting how profitability responded to factors such as patient volumes, pricing and operating costs across the company’s network of hospitals and centers.

Profitability and margins under scrutiny

Investors in CCM stock closely examine operating profit and margins from Concord Medical Services Holdings’ latest reported period. The company’s operating income for that fiscal year stood in the multi-million USD range, and the corresponding operating margin underscored how efficiently it converts revenue from medical services into earnings after staff, equipment, lease and administrative expenses.

A key comparison for CCM stock is how Concord Medical Services Holdings’ latest revenue and profit figures stack up against the prior year. The most recent fiscal year saw revenue grow at a mid-single-digit percentage rate compared with the preceding fiscal year, while net profit moved by a double-digit percentage in the opposite direction, signaling that profitability did not follow revenue growth one-to-one and that margin pressure or higher investment costs played a role.

Representative hospital network product

One representative part of Concord Medical Services Holdings' business behind CCM stock is its network of specialty cancer hospitals and radiotherapy centers. These facilities form a core product offering, providing advanced radiation therapy, imaging and oncology services to patients across multiple regions. In the latest reported period, patient volumes in these centers and related service revenues contributed a substantial portion of the company's overall revenue, illustrating how demand for specialized treatment underpins the earnings power of CCM stock.

Stock view with market data

From an equity-market perspective, CCM stock trades in the United States under ISIN US20601T1016, and its market capitalization is anchored by the most recent share price and shares outstanding as of September 4, 2026. The current share price, combined with the latest trailing revenue and profit figures, implies a valuation multiple that investors use to compare CCM stock with other healthcare and hospital operators listed globally.

CCM stock at a glance

• Company: Concord Medical Services Holdings Ltd.
• ISIN: US20601T1016
• Ticker: CCM
• Trading venue: NASDAQ
• Sector / Industry: Health Care / Hospitals
• Index membership: None (U.S. small cap universe)